Published in Curr Opin Gastroenterol on May 01, 2006
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17
Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol (2011) 2.11
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine. Ecancermedicalscience (2014) 0.95
Survival analysis of cholangiocarcinoma: a 10-year experience in Malaysia. World J Gastroenterol (2012) 0.91
Single operator choledochoscopy and its role in daily endoscopy routine. World J Gastrointest Endosc (2013) 0.88
Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies. World J Gastroenterol (2007) 0.86
Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol (2006) 0.85
Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit (2013) 0.84
MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. BMC Cancer (2014) 0.83
5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy. Int J Nanomedicine (2012) 0.83
Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells. Evid Based Complement Alternat Med (2013) 0.81
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS One (2010) 0.81
Cholangiocarcinoma: a 7-year experience at a single center in Greece. World J Gastroenterol (2008) 0.79
Hepatitis B virus infection and intrahepatic cholangiocarcinoma. World J Gastroenterol (2014) 0.77
Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma. Drug Des Devel Ther (2015) 0.76
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. Onco Targets Ther (2016) 0.75
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology (2007) 13.20
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology (2006) 7.06
Surgical treatment of permanent diaphragm paralysis after interscalene nerve block for shoulder surgery. Anesthesiology (2013) 4.25
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology (2011) 2.90
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology (2009) 2.29
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology (2010) 2.23
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A (2010) 1.99
The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem (2007) 1.90
Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A (2010) 1.87
A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine (Phila Pa 1976) (2004) 1.86
Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol (2002) 1.83
Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res (2006) 1.80
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol (2012) 1.74
Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes. J Hepatol (2005) 1.69
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65
Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol (2007) 1.56
miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res (2011) 1.51
Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. Genes Cancer (2013) 1.47
Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int (2006) 1.45
Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report. J Hematol Oncol (2008) 1.43
MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors. Hepatology (2008) 1.43
The role of microRNAs in human liver cancers. Semin Oncol (2011) 1.34
Identifying opportunities for improved colorectal cancer screening in primary care. Prev Med (2004) 1.26
Long noncoding RNA in liver diseases. Hepatology (2014) 1.23
gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway. Cancer Res (2005) 1.23
Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin Cancer Res (2010) 1.17
Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine (Phila Pa 1976) (2005) 1.12
Translational regulation of x-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival. Cancer Res (2004) 1.09
Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci (2014) 1.09
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study. Spine (Phila Pa 1976) (2008) 1.09
Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J Bone Joint Surg Am (2004) 1.09
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J (2007) 1.08
Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. Biol Psychiatry (2005) 1.07
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. Hepatology (2011) 1.07
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. Am J Physiol Gastrointest Liver Physiol (2003) 1.05
A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J (2003) 1.05
Inhibition of cholangiocarcinoma growth by tannic acid. Hepatology (2003) 1.04
Current approaches to the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep (2006) 1.03
Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes. Life Sci (2005) 1.02
The role of melatonin in anaesthesia and critical care. Indian J Anaesth (2013) 1.02
A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J (2005) 0.99
Non-coding RNAs as therapeutic targets in hepatocellular cancer. Curr Cancer Drug Targets (2012) 0.96
Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol (2004) 0.96
Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma. Mol Pharmacol (2009) 0.94
Cholangiocarcinoma: new insights into disease pathogenesis and biology. Infect Dis Clin North Am (2010) 0.94
Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity. Hepatology (2002) 0.94
Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. Liver Int (2009) 0.93
Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth. Hepatology (2003) 0.93
Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer. PLoS One (2013) 0.93
microRNAs in liver disease: from diagnostics to therapeutics. Clin Biochem (2013) 0.91
Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience. Liver Int (2014) 0.90
Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. Cancer (2009) 0.89
Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med (2012) 0.89
The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model. Invest Radiol (2006) 0.89
Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways. J Hepatol (2006) 0.88
Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study. J Clin Gastroenterol (2009) 0.88
Increased susceptibility of cholangiocytes to tumor necrosis factor-alpha cytotoxicity after bile duct ligation. Am J Physiol Cell Physiol (2003) 0.87
Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer. Brief Funct Genomics (2015) 0.87
Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest. Am J Physiol Cell Physiol (2003) 0.87
Isolation of extracellular nanovesicle microRNA from liver cancer cells in culture. Methods Mol Biol (2013) 0.87
IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway. Am J Physiol Cell Physiol (2005) 0.86
Translational regulation of XIAP expression and cell survival during hypoxia in human cholangiocarcinoma. Gastroenterology (2004) 0.84
Chemotherapeutic stress selectively activates NF-kappa B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells. Am J Physiol Cell Physiol (2007) 0.83
A single-institute experience with sorafenib in untreated and previously treated patients with advanced hepatocellular carcinoma. Oncology (2010) 0.82
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS One (2010) 0.81
Fine-needle aspiration of metanephric adenoma of the kidney with clinical, radiographic and histopathologic correlation: a review. Diagn Cytopathol (2013) 0.81
Double-stranded RNA activates a p38 MAPK-dependent cell survival program in biliary epithelia. Am J Physiol Gastrointest Liver Physiol (2003) 0.81
Tannic acid inhibits cholangiocyte proliferation after bile duct ligation via a cyclic adenosine 5',3'-monophosphate-dependent pathway. Am J Pathol (2005) 0.80
Effect of thermal stability on protein adsorption to silica using homologous aldo-keto reductases. Protein Sci (2012) 0.80
Screening for colorectal cancer in elderly persons: who should we screen and when can we stop? J Aging Health (2007) 0.80
An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis. J Assoc Physicians India (2011) 0.80
Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma. Gene Expr (2014) 0.80
Molecular diagnosis of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2014) 0.79
Pifithrin-alpha enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes. J Pharmacol Exp Ther (2006) 0.79
Autoimmune cholangiopathy and high-output heart failure in a patient with graves disease. Gastroenterol Hepatol (N Y) (2011) 0.79
Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla. Invest Radiol (2005) 0.78
Direct costs of hospitalization for rotavirus gastroenteritis in different health facilities in India. Indian J Med Res (2012) 0.77
Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl (2015) 0.77
Molecular evolution of genetic susceptibility to hepatocellular carcinoma. Dig Dis Sci (2013) 0.76
Can preoperative radiographic parameters be used to predict fusion in non-instrumented posterolateral fusion for degenerative spondylolisthesis? Spine (Phila Pa 1976) (2011) 0.76
Preneoplastic conditions underlying bile duct cancer. Langenbecks Arch Surg (2012) 0.75
Formulation of fenofibrate liquisolid tablets using central composite design. Curr Drug Deliv (2014) 0.75
Prevalence of tuberculosis infection among children in slums of Ahmedabad. Indian Pediatr (2003) 0.75